This is of particular interest given that the H1 MAPT haplotype has consistently been shown to be the risk haplotype for other neurodegenerative disorders including dementia in Parkinson’s disease (Williams-Gray et al., 2009). This evidence concerns the gene MAPT and Parkinson disease.